» Articles » PMID: 25499462

AKT and MET Signalling Mediates Antiapoptotic Radioresistance in Head Neck Cancer Cell Lines

Overview
Journal Oral Oncol
Publisher Elsevier
Specialty Dentistry
Date 2014 Dec 16
PMID 25499462
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Induction of apoptosis is a major mechanism of radiosensitivity in different types of cancer. In contrast, EGFR/PI3K/AKT signalling and recently the presence of so-called cancer stem cells are discussed as reasons for radioresistance.

Materials And Methods: The study investigates mechanisms of apoptosis, key oncogenes of the PI3K/AKT pathway and the presence of cancer cells with stem cell properties during irradiation in two cell lines (PCI-9A, and PCI-15) of head and neck squamous cell carcinoma. WST-1-tests, qRT-PCR, western blots and FACS analysis were performed for analysis.

Results: The two cell lines presented different degrees of cell death upon irradiation. The radiosensitive cell line PCI-9A showed increased apoptosis after irradiation measured by expressed cleaved caspases 3 and 7 while the radioresistant cell line PCI-15 upregulated antiapoptotic Survivin and BCL2A1 mRNA. Besides, increased PI3K/AKT- and ERK1/2-signalling was associated with radioresistance accompanied by loss of PTEN function through phosphorylation on S380. Blockade of pAKT increased radiation-induced cell death, and moreover, led to an upregulation of pMET in the radioresistant cell line. The percentage of ALDH-positive tumour cells was markedly decreased after irradiation in the radiosensitive cell line.

Conclusions: Functional apoptosis is mandatory for sensitivity to irradiation in head neck cancer cells. Upregulation of the AKT-pathway seems to be one reason for poor radioresponse. Activated MET may also predict radioresistance, possibly through ERK1/2 signalling. Moreover MET may indicate the presence of cancer stem cells facilitating radioresistance as shown by increased ALDH expression.

Citing Articles

The anti-oncogenic effect of 17-DMAG via the inactivation of HSP90 and MET pathway in osteosarcoma cells.

Kawano M, Tanaka K, Itonaga I, Iwasaki T, Kubota Y, Tsumura H Oncol Res. 2023; 31(5):631-643.

PMID: 37547755 PMC: 10398415. DOI: 10.32604/or.2023.029745.


Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials.

Harsha C, Banik K, Ang H, Girisa S, Vikkurthi R, Parama D Int J Mol Sci. 2020; 21(9).

PMID: 32384682 PMC: 7246494. DOI: 10.3390/ijms21093285.


Circumventing AKT-Associated Radioresistance in Oral Cancer by Novel Nanoparticle-Encapsulated Capivasertib.

Lang L, Lam T, Chen A, Jensen C, Duncan L, Kong F Cells. 2020; 9(3).

PMID: 32106632 PMC: 7140405. DOI: 10.3390/cells9030533.


PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.

Riva G, Pecorari G, Biolatti M, Pautasso S, Lo Cigno I, Garzaro M Mol Biol Rep. 2019; 46(3):3333-3347.

PMID: 30980272 DOI: 10.1007/s11033-019-04795-7.


The Role of PI3K in Met Driven Cancer: A Recap.

Hervieu A, Kermorgant S Front Mol Biosci. 2018; 5:86.

PMID: 30406111 PMC: 6207648. DOI: 10.3389/fmolb.2018.00086.